Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Int J Afr Nurs Sci ; 18: 100573, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37101536

RESUMEN

In 2022, nursing faculty reflect on the transition without global or national benchmarks or blueprints of a South African Nursing Education Institution to online education during the Covid-19 pandemic. Objective: To provide policy makers a resource in preparation for future crises in education. A theoretical-reflective study supported by a SWOT analysis aimed to understand the transition to online teaching and learning and assessments for the Nursing Discipline (nursing faculty n = 22; undergraduate students n = 291) of a select South African university. It revealed four key lessons learned. Firstly, whether change is planned or unplanned, policy frameworks should guide it. Secondly, resources exist within faculty, and at times, change agents might not be necessary as strengths can be drawn from within. Thirdly, through managing a crisis, faculty-service partnership can be strengthened. Lastly, a need exists for continual surveillance as the inequality gap in Higher Education students has become increasingly visible and amplified further marginalisation. Our reflections have highlighted that opportunities and strengths abound as the pandemic has fast-tracked nursing education institutions to embrace technology for teaching and learning and assessments. Three of the key lessons learned emphasise what is known about the successful outcome of working together.

2.
S Afr Med J ; 111(5): 416-420, 2021 04 30.
Artículo en Inglés | MEDLINE | ID: mdl-34852881

RESUMEN

Digital technologies continue to penetrate the South African (SA) healthcare sector at an increasing rate. Clinician-to-clinician diagnostic and management assistance through mHealth is expanding rapidly, reducing professional isolation and unnecessary referrals, and promoting better patient outcomes and more equitable healthcare systems. However, the widespread uptake of mHealth use raises ethical concerns around patient autonomy and safety, and guidance for healthcare workers around the ethical use of mHealth is needed. This article presents the results of a multi-stakeholder workshop at which the 'dos and don'ts' pertaining to mHealth ethics in the SA context were formulated and aligned to seven basic recommendations derived from the literature and previous multi-stakeholder, multi-country meetings.


Asunto(s)
Atención a la Salud/organización & administración , Personal de Salud/organización & administración , Telemedicina/organización & administración , Atención a la Salud/ética , Humanos , Autonomía Personal , Derivación y Consulta , Sudáfrica , Telemedicina/ética
3.
bioRxiv ; 2021 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-34159332

RESUMEN

The continuing emergence of SARS-CoV-2 variants calls for regular assessment to identify differences in viral replication, shedding and associated disease. In this study, African green monkeys were infected intranasally with either a contemporary D614G or the UK B.1.1.7 variant. Both variants caused mild respiratory disease with no significant differences in clinical presentation. Significantly higher levels of viral RNA and infectious virus were found in upper and lower respiratory tract samples and tissues from B.1.1.7 infected animals. Interestingly, D614G infected animals showed significantly higher levels of viral RNA and infectious virus in rectal swabs and gastrointestinal tract tissues. Our results indicate that B.1.1.7 infection in African green monkeys is associated with increased respiratory replication and shedding but no disease enhancement similar to human B.1.1.7 cases. ONE-SENTENCE SUMMARY: UK B.1.1.7 infection of African green monkeys exhibits increased respiratory replication and shedding but no disease enhancement.

4.
Nutr Diabetes ; 7(10): e288, 2017 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-28991222

RESUMEN

Although whole-fruit consumption is regarded as protective against type 2 diabetes (T2DM), conventionally prepared fruit juice is associated with increased T2DM risk, and current public health advice recommends its restriction. 'Nutrient extractor' style blenders are increasing in popularity worldwide as an alternative means of juicing fruit, but little is known about their effect on postprandial glucose levels. The current study investigated the effect of nutrient extraction on postprandial blood glucose response and glycemic index (GI) compared with a glucose control for both mixed fruit and a high GI fruit (mango). Remarkably, consumption of nutrient-extracted mixed fruit resulted in a significant lowering of the GI (32.7±8.5) compared with whole mixed fruit (66.2±8.2, P<0.05). For the high GI mango, there were no differences between nutrient-extracted and whole fruit, indicating that even for a high GI fruit the effect of nutrient extraction does not increase GI compared with the whole fruit. These findings suggest that, in contrast to conventionally prepared fruit juice, fruit juice prepared by nutrient extraction in some cases elicits a more favorable postprandial glycemic response than whole fruit and even for high GI fruits do not worsen the response. The mechanism responsible for this effect is currently unclear. However, these results suggest that fruit homogenized by nutrient extraction should be considered as a potential dietetic strategy for glycemic control.


Asunto(s)
Glucemia/análisis , Manipulación de Alimentos/métodos , Jugos de Frutas y Vegetales/análisis , Periodo Posprandial , Adulto , Estudios Cruzados , Diabetes Mellitus Tipo 2 , Femenino , Frutas , Índice Glucémico , Humanos , Cinética , Masculino , Mangifera , Factores de Riesgo
5.
Ann Thorac Surg ; 70(4): 1362-5, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11081899

RESUMEN

BACKGROUND: Allen's test is widely used to assess the ulnar collateral blood supply of the hand before radial artery harvest for coronary bypass surgery. This study was performed to determine the optimum cut-off point for a positive Allen's test and the clinical reliability of Allen's test in this role. METHODS: Patients undergoing coronary artery bypass surgery were examined by independent observers using both Allen's test and a Doppler ultrasound test of the ulnar collateral circulation. RESULTS: We examined 93 hands in 47 patients; mean age was 63.6 years. Receiver operating characteristic analysis found that at a conventional cut-off of 6 seconds on Allen's test had a sensitivity of 54.5%, specificity of 91.7%, and diagnostic accuracy of 78.5%. At a cut-off of 5 seconds diagnostic accuracy was maximal (79.6%), with sensitivity of 75.8% and specificity of 81.7%; 100% sensitivity occurred at a cut-off of 3 seconds, with specificity of 27% and diagnostic accuracy of 52%. CONCLUSIONS: At no cut-off point does Allen's test perform satisfactorily as a discriminatory test. It should be replaced by more objective tests, such as Doppler ultrasound.


Asunto(s)
Puente de Arteria Coronaria/métodos , Mano/irrigación sanguínea , Selección de Paciente , Arteria Radial/trasplante , Recolección de Tejidos y Órganos , Anciano , Velocidad del Flujo Sanguíneo/fisiología , Circulación Colateral/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Ultrasonografía Doppler
6.
Virology ; 268(1): 94-103, 2000 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-10683331

RESUMEN

Development of an effective preventive or therapeutic vaccine against HIV-1 is an important goal in the fight against AIDS. Effective virus clearance and inhibition of spread to target organs depends principally on the cellular immune response. Therefore, a vaccine against HIV-1 should elicit virus-specific cytotoxic lymphocyte (CTL) responses to eliminate the virus during the cell-associated stages of its life cycle. The vaccine should also be capable of inducing immunity at the mucosal surfaces, the primary route of transmission. Recombinant Bacille Calmette-Guérin (BCG) expressing viral proteins offers an excellent candidate vaccine in view of its safety and ability to persist intracellularly, resulting in the induction of long-lasting immunity and stimulation of the cellular immune response. BCG can be administered orally to induce HIV-specific immunity at the mucosal surfaces. The immunogenicity of four recombinant BCG constructs expressing simian immunodeficiency virus (SIV) Gag, Pol, Env, and Nef proteins was tested in rhesus macaques. A single simultaneous inoculation of all four recombinants elicited SIV-specific IgA and IgG antibody, and cellular immune responses, including CTL and helper T cell proliferation. Our results demonstrate that BCG recombinant vectors can induce concomitant humoral and cellular immune responses to the major proteins of SIV.


Asunto(s)
Anticuerpos Antivirales/sangre , Vacunas contra el SIDAS/inmunología , Virus de la Inmunodeficiencia de los Simios/inmunología , Linfocitos T Citotóxicos/inmunología , Vacunas Sintéticas/inmunología , Proteínas Virales/inmunología , Animales , Vacuna BCG/genética , Vacuna BCG/inmunología , Western Blotting , Clonación Molecular , Citotoxicidad Inmunológica , Productos del Gen env/genética , Productos del Gen env/inmunología , Productos del Gen env/metabolismo , Productos del Gen gag/genética , Productos del Gen gag/inmunología , Productos del Gen gag/metabolismo , Productos del Gen nef/genética , Productos del Gen nef/inmunología , Productos del Gen nef/metabolismo , Productos del Gen pol/genética , Productos del Gen pol/inmunología , Productos del Gen pol/metabolismo , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Activación de Linfocitos , Macaca mulatta , Vacunas contra el SIDAS/genética , Síndrome de Inmunodeficiencia Adquirida del Simio/prevención & control , Virus de la Inmunodeficiencia de los Simios/genética , Virus de la Inmunodeficiencia de los Simios/metabolismo , Vacunación , Vacunas Sintéticas/genética , Proteínas Virales/genética , Proteínas Virales/metabolismo
7.
Proc Natl Acad Sci U S A ; 97(6): 2864-9, 2000 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-10681468

RESUMEN

Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, alpha(1)-PDX. This protein is a potent and selective furin inhibitor (K(i) = 0.6 nM) and is 10-fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad-based anti-pathogens.


Asunto(s)
Infecciones por Citomegalovirus/tratamiento farmacológico , alfa 1-Antitripsina/uso terapéutico , Western Blotting , Citomegalovirus/metabolismo , Relación Dosis-Respuesta a Droga , Fibroblastos/citología , Fibroblastos/metabolismo , Furina , Humanos , Cinética , Microscopía Fluorescente , Pruebas de Precipitina , Subtilisinas/antagonistas & inhibidores , Factores de Tiempo , Células Tumorales Cultivadas , alfa 1-Antitripsina/metabolismo , alfa 1-Antitripsina/toxicidad
8.
ASAIO J ; 45(5): 488-95, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10503631

RESUMEN

The sheep has been the standard laboratory animal for extracorporeal membrane oxygenation (ECMO) research for many years and has proven to be an invaluable and reliable model. However the coagulation system of the sheep is significantly different from humans. These differences make it difficult to investigate the coagulative and inflammatory response to ECMO in sheep. The pig has a very similar coagulation system to humans and therefore makes a more appropriate model. We describe a porcine model of prolonged (48 hours) closed chest venovenous (VV) ECMO that we developed to investigate the inflammatory and coagulative response to different ECMO tubing materials. This model could be used to investigate any aspect of venovenous ECMO.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Animales , Cateterismo , Oxigenación por Membrana Extracorpórea/efectos adversos , Femenino , Hígado/fisiología , Porcinos
9.
Arch Intern Med ; 159(9): 913-24, 1999 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-10326934

RESUMEN

Patients with substance abuse problems are common in general medical practice and include people of all ages and socioeconomic groups. Initial diagnosis and treatment of addiction problems are often done by the primary care practitioner before referral to a specialist. This article provides information to help in recognition of addiction, guidelines for treatment of intoxication and withdrawal of various drugs of abuse (such as opioids, sedative-hypnotics, stimulants, hallucinogens, and volatile inhalants), and techniques for brief intervention as well as long-term care of substance-abusing patients. The physician can be a powerful influence for getting the patient to accept treatment, especially when the physician is empathic without being judgmental. Addiction is a chronic disorder with remissions and relapses like any other chronic disease, so exacerbations should not be seen as failures but as time to intensify treatment. Patients with substance abuse problems can be frustrating to treat, but it can also be a rewarding experience when a physician helps a substance-abusing patient return to normal and productive functioning in society.


Asunto(s)
Rol del Médico , Atención Primaria de Salud , Trastornos Relacionados con Sustancias , Enfermedad Aguda , Estimulantes del Sistema Nervioso Central/efectos adversos , Enfermedad Crónica , Diagnóstico Diferencial , Alucinógenos/efectos adversos , Humanos , Hipnóticos y Sedantes/efectos adversos , Trastornos Relacionados con Opioides/diagnóstico , Trastornos Relacionados con Opioides/terapia , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/terapia
10.
J Virol ; 73(6): 4552-60, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10233913

RESUMEN

Epithelial cells are known to be a major target for human cytomegalovirus (HCMV) infection; however, the analysis of virus-cell interactions has been difficult to approach due to the lack of in vitro models. In this study, we established a polarized epithelial cell model using a colon epithelial cell-derived cell line (Caco-2) that is susceptible to HCMV infection at early stages of cellular differentiation. Infection of polarized cells was restricted to the basolateral surface whereas virus was released apically, which was consistent with the apical and not basolateral surface localization of two essential viral glycoproteins, gB and gH. HCMV infection resulted in the development of a cytopathology characteristic of HCMV infection of colon epithelium in vivo, and infection did not spread from cell to cell. The inability of HCMV to infect Caco-2 cells at late stages of differentiation was due to a restriction at the level of viral entry and was consistent with the sequestration of a cellular receptor for HCMV. These observations provide the first evidence that restriction of HCMV replication in epithelial cells is due to a receptor-mediated phenomenon.


Asunto(s)
Citomegalovirus/fisiología , Células CACO-2 , Diferenciación Celular , Membrana Celular/virología , Polaridad Celular , Humanos , Cuerpos de Inclusión , Receptores Virales/fisiología , Proteínas del Envoltorio Viral/análisis
11.
J Addict Dis ; 18(4): 51-61, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10631963

RESUMEN

Traditionally, methadone maintenance therapy has been a once-daily dosing schedule. The current study evaluates the effectiveness of this regimen during pregnancy. A total of 23 pregnant and 16 non-pregnant opioid-dependent patients were studied in two phases to evaluate pregnancy-dependent changes in methadone pharmacokinetics. In the first phase, pregnant patients had a statistically significant higher elimination rate constant (k) and lower half-life compared to non-pregnant controls. In the second phase, the apparent clearance (Cl/F) was significantly greater during pregnancy, with preliminary data suggesting that this observation results from a decrease in the fraction of dose absorbed (F). The implications of these findings on dosing regimens during pregnancy is discussed.


Asunto(s)
Metadona/farmacocinética , Narcóticos/farmacocinética , Trastornos Relacionados con Opioides/rehabilitación , Complicaciones del Embarazo/rehabilitación , Adulto , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Semivida , Humanos , Metadona/administración & dosificación , Metadona/uso terapéutico , Narcóticos/administración & dosificación , Narcóticos/uso terapéutico , Embarazo , Tercer Trimestre del Embarazo/fisiología
12.
Thromb Haemost ; 75(2): 318-25, 1996 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8815584

RESUMEN

Hemophilia A is a clotting disorder that is due to reduced or absent coagulation factor VIII (FVIII) activity. In approximately 25% of people with severe hemophilia A, standard treatment with intravenous plasma-derived or recombinant FVIII (rFVIII) induces anti-FVIII antibodies that inhibit FVIII activity (inhibitors). We describe the development of a rat model to study the formation of inhibitors. Immunization of rats with human rFVIII in adjuvant induced an anti-human rFVIII antibody response characteristic of an anti-FVIII inhibitor response in hemophilia A patients. The rats exhibited a rapid, polyclonal secondary antibody response to human rFVIII. These antibodies were reactive against epitopes located in the heavy and light chains. All the rFVIII-immunized rats developed antibodies against the FVIII C2 domain, a region of major reactivity in hemophilia A patients with inhibitors. Furthermore, competition ELISAs demonstrated that rat and human anti-FVIII antibodies recognized identical or overlapping epitopes of the FVIII molecule. The rat anti-FVIII antibodies also functioned as human FVIII inhibitors with titers ranging from 120 to 2048 Bethesda Units (B.U.). We propose that this rat model may be useful to investigate immune responses to FVIII and may lead to better therapies for FVIII inhibitors.


Asunto(s)
Anticuerpos/inmunología , Modelos Animales de Enfermedad , Factor VIII/inmunología , Fragmentos de Péptidos/inmunología , Proteínas Recombinantes/inmunología , Animales , Formación de Anticuerpos , Ensayo de Inmunoadsorción Enzimática , Factor VIII/administración & dosificación , Factor VIII/antagonistas & inhibidores , Hemofilia A , Humanos , Inmunización , Inmunización Secundaria , Memoria Inmunológica , Isoanticuerpos/inmunología , Focalización Isoeléctrica , Masculino , Tiempo de Tromboplastina Parcial , Fragmentos de Péptidos/administración & dosificación , Fenotipo , Ratas , Ratas Sprague-Dawley , Trombina/metabolismo
14.
J Psychoactive Drugs ; 26(2): 155-61, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7931860

RESUMEN

Methadone maintenance has been used for decades to treat opioid-dependent pregnant women. The outcomes of pregnancies thus treated are vastly improved over the outcomes of pregnancies complicated by street drug use. Despite its long history of successful use during pregnancy, little is known about the long-term effects of methadone on the fetus and the newborn. Studies done in animals suggest there may be subtle effects on brain and behavior. Only recently have other treatments for opioid dependency during pregnancy been investigated. There is increasing evidence that altering the traditional methadone maintenance protocols may be beneficial, and that tapered withdrawal can be safely achieved under some circumstances.


Asunto(s)
Metadona/uso terapéutico , Trastornos Relacionados con Opioides/complicaciones , Trastornos Relacionados con Opioides/rehabilitación , Complicaciones del Embarazo/terapia , Femenino , Humanos , Metadona/efectos adversos , Embarazo , Resultado del Embarazo
19.
W V Med J ; 62(2): 47-8, 1966 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-5216670
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA